Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling

被引:16
作者
Jiang, Jiahua [1 ]
Grieb, Brian [1 ]
Thyagarajan, Anita [1 ]
Sliva, Daniel [1 ,2 ,3 ]
机构
[1] Methodist Res Inst, Canc Res Lab, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA
[3] Indiana Univ, Sch Med, Simon Canc Ctr, Indianapolis, IN 46204 USA
关键词
breast cancer; invasiveness; mushroom triterpenes; ganoderic acids; urokinase-type plasminogen activator; cdk4;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Structurally related lanostane-type triterpenes, ganoderic acid A, F and H (GA-A, GA-F, GA-H), were identified in an oriental medicinal mushroom Ganoderma lucidum. In the present study we evaluated the effect of GA-A, GA-H and GA-F on highly invasive human breast cancer cells. We showed that GA-A and GA-H suppressed growth (cell proliferation and colony formation) and invasive behavior (adhesion, migration and invasion) of MDA-MB-231 cells. Our results suggest that GA-A and GA-H mediate their biological effects through the inhibition of transcription factors AP-1 and NF-kappa B, resulting in the down-regulation of expression of Cdk4 and the suppression of secretion of uPA, respectively. Furthermore, the activity of ganoderic acids is linked to the hydroxylation in the position 7 and 15 (GA-A) and 3 (GA-H) in their triterpene lanostane structure. In conclusion, hydroxylated triterpenes from G. lucidum could be promising natural agents for the therapy of invasive breast cancers.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 34 条
[1]   Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum [J].
Akihisa, Toshihiro ;
Nakamura, Yuji ;
Tagata, Masaaki ;
Tokuda, Harukuni ;
Yasukawa, Ken ;
Uchiyama, Emiko ;
Suzuki, Takashi ;
Kimura, Yumiko .
CHEMISTRY & BIODIVERSITY, 2007, 4 (02) :224-231
[2]   Molecular regulation of an invasion-related molecule - options for turnour staging and clinical strategies [J].
Allgayer, Heike .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (07) :811-819
[3]  
[Anonymous], J CANC INTEGR MED
[4]   Urokinase-type plasminogen activator [J].
Crippa, Massimo P. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04) :690-694
[5]   Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells [J].
Daschner, PJ ;
Ciolino, HP ;
Plouzek, CA ;
Yeh, GC .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (03) :229-240
[6]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[7]   Selected novel anticancer treatments targeting cell signaling proteins [J].
Elsayed, YA ;
Sausville, EA .
ONCOLOGIST, 2001, 6 (06) :517-537
[8]   New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells [J].
Gao, JJ ;
Min, BS ;
Ahn, EM ;
Nakamura, N ;
Lee, HK ;
Hattori, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2002, 50 (06) :837-840
[9]   Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties [J].
Gao, YH ;
Zhou, SF .
FOOD REVIEWS INTERNATIONAL, 2003, 19 (03) :275-325
[10]   Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors [J].
Hajjaj, H ;
Macé, C ;
Roberts, M ;
Niederberger, P ;
Fay, LB .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (07) :3653-3658